| Page 20 | Kisaco Research
 

Nikkia Starks

Chief Revenue Officer
Bitwerx

Nikkia Starks

Chief Revenue Officer
Bitwerx

Nikkia Starks

Chief Revenue Officer
Bitwerx
 

Mark Baghdassarian

Partner
McDermott Will & Schulte

Mark Baghdassarian

Partner
McDermott Will & Schulte

Mark Baghdassarian

Partner
McDermott Will & Schulte
 

Jeremy Lowe

Partner
Spencer Fane LLP

Jeremy Lowe

Partner
Spencer Fane LLP

Jeremy Lowe

Partner
Spencer Fane LLP
 

Charlotte Kufus

Co-Founder
Flank

Charlotte Kufus is a co-founder at Flank, which builds supervised AI agents that handle high volume contracting workflows end-to-end. She is an LSE graduate and has been listed in Forbes 30 Under 30.

Charlotte Kufus

Co-Founder
Flank

Charlotte Kufus

Co-Founder
Flank

Charlotte Kufus is a co-founder at Flank, which builds supervised AI agents that handle high volume contracting workflows end-to-end. She is an LSE graduate and has been listed in Forbes 30 Under 30.

 

Brian P. Murray

Partner
Neal Gerber Eisenberg

Brian counsels clients across the biotechnology, pharmaceutical, chemical, and engineering industries on complex intellectual property and technology disputes. He represents companies in high-stakes patent litigation involving biotechnology and biosynthesis, pharmaceuticals, plastics, telecommunications, and LED technologies, helping clients align legal strategies with scientific, regulatory, and business objectives.

Brian P. Murray

Partner
Neal Gerber Eisenberg

Brian P. Murray

Partner
Neal Gerber Eisenberg

Brian counsels clients across the biotechnology, pharmaceutical, chemical, and engineering industries on complex intellectual property and technology disputes. He represents companies in high-stakes patent litigation involving biotechnology and biosynthesis, pharmaceuticals, plastics, telecommunications, and LED technologies, helping clients align legal strategies with scientific, regulatory, and business objectives.

Drawing on his background in pharmaceutical research and development, Brian represents clients in Hatch-Waxman litigation and has helped guide multiple matters through trial.  He also advises those pharmaceutical clients on pre-suit strategy, product selection, portfolio management, formulation development, labeling considerations, and regulatory matters.

A significant portion of Brian’s practice focuses on biotechnology innovators, particularly those developing bioengineering and fermentation technologies. He has extensive experience litigating patents related to metabolic engineering and microbial strain development and is skilled at translating highly technical concepts into clear, compelling litigation and counseling strategies.

Before attending law school, Brian worked as a formulation development scientist at Caraco Pharmaceutical Laboratories and gained experience in pharmaceutical synthesis at Fabbrica Italiana Sintetici S.p.A., providing him with a practical understanding of the industries he serves.

 
1 Oct 2027
JW Marriott Hotel, Los Angeles
Step into beauty & wellness' inner circle. Welcome to Beauty Connect, where the beauty and wellness industry’s most influential brands meet to innovate, collaborate, and grow.